NIDDK Renews License to GeneGo's MetaCore Software | GenomeWeb
NEW YORK (GenomeWeb News) — GeneGo said today that that the National Institute of Diabetes and Digestive and Kidney Diseases has renewed its MetaCore license to continue researching insulin-resistant diabetes in human and animal models.
Tatiana Nikolskaya, chief scientific officer and president of GeneGo, said the collaboration "is a very important part of our development program in this field."
Financial details were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.